世界の体外診断市場2020-2025:組織診断、専門診断、分子診断、糖尿病モニタリング

【英語タイトル】Global In-Vitro Diagnostics Market Growth 2020-2025

LP Informationが出版した調査資料(LPI20AP2353)・商品コード:LPI20AP2353
・発行会社(調査会社):LP Information
・発行日:2020年3月2日
・ページ数:180
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single UserUSD3,660 ⇒換算¥380,640見積依頼/購入/質問フォーム
Multi UserUSD5,490 ⇒換算¥570,960見積依頼/購入/質問フォーム
Corporate UserUSD7,320 ⇒換算¥761,280見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
「体外診断の世界市場」は、地域的には米州、アジア、欧州、中東・アフリカ市場をカバーしており、種類別には、組織診断、専門診断、分子診断、糖尿病モニタリングなど、用途別には、糖尿病、感染症、腫瘍学、循環器学、HIV、その他などに区分してまとめた調査レポートです。体外診断のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が含まれています。
・体外診断の世界市場概要(サマリー)
・体外診断の企業別販売量・売上
・体外診断の企業別市場シェア
・体外診断の世界市場規模 2015年-2020年:種類別(組織診断、専門診断、分子診断、糖尿病モニタリング)
・体外診断の世界市場規模 2015年-2020年:用途別(糖尿病、感染症、腫瘍学、循環器学、HIV、その他)
・体外診断の米州市場規模(アメリカ、カナダ、メキシコなど)
・体外診断のアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・体外診断の欧州市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・体外診断の中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・体外診断市場の成長要因・課題・動向
・体外診断の世界市場予測 2021年-2025年
・体外診断の米州市場予測(アメリカ、カナダ、メキシコなど)
・体外診断のアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・体外診断の欧州市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・体外診断の中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・体外診断の世界市場予測:種類別(組織診断、専門診断、分子診断、糖尿病モニタリング)
・体外診断の世界市場予測:用途別(糖尿病、感染症、腫瘍学、循環器学、HIV、その他)
・主要企業分析
【レポートの概要】

According to this study, over the next five years the In-Vitro Diagnostics market will register a 4.6% CAGR in terms of revenue, the global market size will reach $ 68930 million by 2025, from $ 57660 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in In-Vitro Diagnostics business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of In-Vitro Diagnostics market by type, application, key manufacturers and key regions and countries.

This study considers the In-Vitro Diagnostics value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Tissue diagnostics
Professional diagnostic
Molecular diagnostic
Diabetes Monitoring

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Diabetes
Infectious Diseases
Oncology
Cardiology
HIV
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Siemens Healthcare
Merck Millipore
Johnson and Johnson
Abbott Laboratories
Roche Diagnostics
Becton Dickinson
Cobas
Beckman Coulter Inc
Caprion
Thermo Scientific
Sysmex Corporation
Shanghai Kehua Bio-engineering
Mindray
Aptiv Solution
Bio-Rad Laboratories
Biomerieux
Beijing Leadman Biochemistry
Ortho Clinical Diagnostics
Danaher Corporation
BioSino Bio-technology
DAAN Gene

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global In-Vitro Diagnostics consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of In-Vitro Diagnostics market by identifying its various subsegments.
Focuses on the key global In-Vitro Diagnostics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the In-Vitro Diagnostics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of In-Vitro Diagnostics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

【レポートの目次】

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global In-Vitro Diagnostics Consumption 2015-2025
2.1.2 In-Vitro Diagnostics Consumption CAGR by Region
2.2 In-Vitro Diagnostics Segment by Type
2.2.1 Tissue diagnostics
2.2.2 Professional diagnostic
2.2.3 Molecular diagnostic
2.2.4 Diabetes Monitoring
2.3 In-Vitro Diagnostics Consumption by Type
2.3.1 Global In-Vitro Diagnostics Consumption Market Share by Type (2015-2020)
2.3.2 Global In-Vitro Diagnostics Revenue and Market Share by Type (2015-2020)
2.3.3 Global In-Vitro Diagnostics Sale Price by Type (2015-2020)
2.4 In-Vitro Diagnostics Segment by Application
2.4.1 Diabetes
2.4.2 Infectious Diseases
2.4.3 Oncology
2.4.4 Cardiology
2.4.5 HIV
2.4.6 Other
2.5 In-Vitro Diagnostics Consumption by Application
2.5.1 Global In-Vitro Diagnostics Consumption Market Share by Type (2015-2020)
2.5.2 Global In-Vitro Diagnostics Value and Market Share by Type (2015-2020)
2.5.3 Global In-Vitro Diagnostics Sale Price by Type (2015-2020)

3 Global In-Vitro Diagnostics by Company
3.1 Global In-Vitro Diagnostics Sales Market Share by Company
3.1.1 Global In-Vitro Diagnostics Sales by Company (2018-2020)
3.1.2 Global In-Vitro Diagnostics Sales Market Share by Company (2018-2020)
3.2 Global In-Vitro Diagnostics Revenue Market Share by Company
3.2.1 Global In-Vitro Diagnostics Revenue by Company (2018-2020)
3.2.2 Global In-Vitro Diagnostics Revenue Market Share by Company (2018-2020)
3.3 Global In-Vitro Diagnostics Sale Price by Company
3.4 Global In-Vitro Diagnostics Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global In-Vitro Diagnostics Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players In-Vitro Diagnostics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 In-Vitro Diagnostics by Regions
4.1 In-Vitro Diagnostics by Regions
4.2 Americas In-Vitro Diagnostics Consumption Growth
4.3 APAC In-Vitro Diagnostics Consumption Growth
4.4 Europe In-Vitro Diagnostics Consumption Growth
4.5 Middle East & Africa In-Vitro Diagnostics Consumption Growth

5 Americas
5.1 Americas In-Vitro Diagnostics Consumption by Countries
5.1.1 Americas In-Vitro Diagnostics Consumption by Countries (2015-2020)
5.1.2 Americas In-Vitro Diagnostics Value by Countries (2015-2020)
5.2 Americas In-Vitro Diagnostics Consumption by Type
5.3 Americas In-Vitro Diagnostics Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC In-Vitro Diagnostics Consumption by Regions
6.1.1 APAC In-Vitro Diagnostics Consumption by Regions (2015-2020)
6.1.2 APAC In-Vitro Diagnostics Value by Regions (2015-2020)
6.2 APAC In-Vitro Diagnostics Consumption by Type
6.3 APAC In-Vitro Diagnostics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe In-Vitro Diagnostics by Countries
7.1.1 Europe In-Vitro Diagnostics Consumption by Countries (2015-2020)
7.1.2 Europe In-Vitro Diagnostics Value by Countries (2015-2020)
7.2 Europe In-Vitro Diagnostics Consumption by Type
7.3 Europe In-Vitro Diagnostics Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa In-Vitro Diagnostics by Countries
8.1.1 Middle East & Africa In-Vitro Diagnostics Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa In-Vitro Diagnostics Value by Countries (2015-2020)
8.2 Middle East & Africa In-Vitro Diagnostics Consumption by Type
8.3 Middle East & Africa In-Vitro Diagnostics Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 In-Vitro Diagnostics Distributors
10.3 In-Vitro Diagnostics Customer

11 Global In-Vitro Diagnostics Market Forecast
11.1 Global In-Vitro Diagnostics Consumption Forecast (2021-2025)
11.2 Global In-Vitro Diagnostics Forecast by Regions
11.2.1 Global In-Vitro Diagnostics Forecast by Regions (2021-2025)
11.2.2 Global In-Vitro Diagnostics Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global In-Vitro Diagnostics Forecast by Type
11.8 Global In-Vitro Diagnostics Forecast by Application

12 Key Players Analysis
12.1 Siemens Healthcare
12.1.1 Company Information
12.1.2 In-Vitro Diagnostics Product Offered
12.1.3 Siemens Healthcare In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Siemens Healthcare Latest Developments
12.2 Merck Millipore
12.2.1 Company Information
12.2.2 In-Vitro Diagnostics Product Offered
12.2.3 Merck Millipore In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Merck Millipore Latest Developments
12.3 Johnson and Johnson
12.3.1 Company Information
12.3.2 In-Vitro Diagnostics Product Offered
12.3.3 Johnson and Johnson In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Johnson and Johnson Latest Developments
12.4 Abbott Laboratories
12.4.1 Company Information
12.4.2 In-Vitro Diagnostics Product Offered
12.4.3 Abbott Laboratories In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Abbott Laboratories Latest Developments
12.5 Roche Diagnostics
12.5.1 Company Information
12.5.2 In-Vitro Diagnostics Product Offered
12.5.3 Roche Diagnostics In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Roche Diagnostics Latest Developments
12.6 Becton Dickinson
12.6.1 Company Information
12.6.2 In-Vitro Diagnostics Product Offered
12.6.3 Becton Dickinson In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Becton Dickinson Latest Developments
12.7 Cobas
12.7.1 Company Information
12.7.2 In-Vitro Diagnostics Product Offered
12.7.3 Cobas In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Cobas Latest Developments
12.8 Beckman Coulter Inc
12.8.1 Company Information
12.8.2 In-Vitro Diagnostics Product Offered
12.8.3 Beckman Coulter Inc In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Beckman Coulter Inc Latest Developments
12.9 Caprion
12.9.1 Company Information
12.9.2 In-Vitro Diagnostics Product Offered
12.9.3 Caprion In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Caprion Latest Developments
12.10 Thermo Scientific
12.10.1 Company Information
12.10.2 In-Vitro Diagnostics Product Offered
12.10.3 Thermo Scientific In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Thermo Scientific Latest Developments
12.11 Sysmex Corporation
12.11.1 Company Information
12.11.2 In-Vitro Diagnostics Product Offered
12.11.3 Sysmex Corporation In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Sysmex Corporation Latest Developments
12.12 Shanghai Kehua Bio-engineering
12.12.1 Company Information
12.12.2 In-Vitro Diagnostics Product Offered
12.12.3 Shanghai Kehua Bio-engineering In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Shanghai Kehua Bio-engineering Latest Developments
12.13 Mindray
12.13.1 Company Information
12.13.2 In-Vitro Diagnostics Product Offered
12.13.3 Mindray In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Mindray Latest Developments
12.14 Aptiv Solution
12.14.1 Company Information
12.14.2 In-Vitro Diagnostics Product Offered
12.14.3 Aptiv Solution In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Aptiv Solution Latest Developments
12.15 Bio-Rad Laboratories
12.15.1 Company Information
12.15.2 In-Vitro Diagnostics Product Offered
12.15.3 Bio-Rad Laboratories In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Bio-Rad Laboratories Latest Developments
12.16 Biomerieux
12.16.1 Company Information
12.16.2 In-Vitro Diagnostics Product Offered
12.16.3 Biomerieux In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Biomerieux Latest Developments
12.17 Beijing Leadman Biochemistry
12.17.1 Company Information
12.17.2 In-Vitro Diagnostics Product Offered
12.17.3 Beijing Leadman Biochemistry In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Beijing Leadman Biochemistry Latest Developments
12.18 Ortho Clinical Diagnostics
12.18.1 Company Information
12.18.2 In-Vitro Diagnostics Product Offered
12.18.3 Ortho Clinical Diagnostics In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.18.4 Main Business Overview
12.18.5 Ortho Clinical Diagnostics Latest Developments
12.19 Danaher Corporation
12.19.1 Company Information
12.19.2 In-Vitro Diagnostics Product Offered
12.19.3 Danaher Corporation In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.19.4 Main Business Overview
12.19.5 Danaher Corporation Latest Developments
12.20 BioSino Bio-technology
12.20.1 Company Information
12.20.2 In-Vitro Diagnostics Product Offered
12.20.3 BioSino Bio-technology In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.20.4 Main Business Overview
12.20.5 BioSino Bio-technology Latest Developments
12.21 DAAN Gene
12.21.1 Company Information
12.21.2 In-Vitro Diagnostics Product Offered
12.21.3 DAAN Gene In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.21.4 Main Business Overview
12.21.5 DAAN Gene Latest Developments

13 Research Findings and Conclusion



★調査レポート[世界の体外診断市場2020-2025:組織診断、専門診断、分子診断、糖尿病モニタリング] (コード:LPI20AP2353)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の体外診断市場2020-2025:組織診断、専門診断、分子診断、糖尿病モニタリング]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆